Eye Cream OEM Formulation Guide: Ingredients, Textures, and Private Label Strategy

The eye contour is the most scrutinised area of the face in consumer skincare research. It is also the area where the gap between what consumers expect and what most products deliver is widest — creating a persistent commercial opportunity for brands that invest in genuinely differentiated eye cream formulation. For private label brands and OEM buyers, understanding the science behind eye cream formulation is not optional: it is the foundation of every product brief, every claim, and every positioning decision that follows.

This guide covers the key active ingredients, texture strategies, clinical efficacy benchmarks, and compliance considerations that define best-in-class eye cream OEM development in 2026.

The Anatomy of the Eye Contour: Why It Requires a Dedicated Formula

The periorbital skin — the skin surrounding the eye — is structurally and functionally distinct from facial skin in ways that directly determine formulation requirements. It is approximately 40% thinner than skin on the cheeks or forehead, has significantly fewer sebaceous glands (meaning lower natural lipid content and faster transepidermal water loss), and is subject to constant mechanical stress from blinking (approximately 15,000 times per day) and facial expression. The result is a microenvironment that is simultaneously more fragile, more prone to dehydration, and more susceptible to the visible signs of aging — fine lines, loss of firmness, puffiness, and dark circles — than any other area of the face.

These structural realities translate directly into formulation requirements. An effective eye cream must deliver intense, sustained hydration without occlusive heaviness that could cause milia (small keratin cysts common in the eye area when heavy emollients are used). It must address multiple concurrent concerns — puffiness, dark circles, fine lines, and loss of firmness — with actives that are tolerated by sensitive periorbital skin. And it must do so in a texture that applies smoothly, layers under makeup without pilling, and absorbs without migrating into the eye itself.

Core Active Ingredients: What the Science Supports

The most commercially validated eye cream actives in 2026 fall into four functional categories: hydration and barrier support, brightening and dark circle reduction, firming and anti-aging, and de-puffing. A well-formulated eye cream addresses all four simultaneously.

Hydration and Barrier Support

Multi-Molecular Weight Hyaluronic Acid remains the gold standard hydration active for the eye area. The multi-molecular approach — combining high-molecular-weight HA (which forms a hydrating film on the surface) with low-molecular-weight HA (which penetrates deeper into the epidermis) and sodium hyaluronate crosspolymer (which provides extended-release hydration) — delivers measurably superior hydration outcomes compared to single-molecular-weight HA. Clinical studies consistently show 30–50% improvements in skin hydration at 4 weeks with multi-molecular HA formulas.

Ceramide NP (and the broader ceramide complex including ceramide AP and EOP) addresses the structural barrier deficiency that makes periorbital skin particularly vulnerable to dehydration. The stratum corneum of the eye area has lower ceramide content than facial skin, and topical ceramide supplementation has been shown to reduce transepidermal water loss and improve barrier function measurably within 2–4 weeks of consistent use. Evonik's Ceramide PC-102 and Ashland's Ceramide Complex are the benchmark supplier ingredients in this category.

Squalane provides lightweight emolliency without the occlusive heaviness that causes milia in the eye area. Derived from sugarcane (the current commercial standard) or olive, squalane is structurally similar to the skin's own sebum and is exceptionally well-tolerated in periorbital applications.

Brightening and Dark Circle Reduction

Dark circles have multiple etiologies — vascular (visible blood vessels through thin skin), pigmentary (post-inflammatory hyperpigmentation or constitutional melanin deposition), and structural (shadowing from orbital fat loss and tear trough hollowing). Effective brightening actives address the first two.

Niacinamide (Vitamin B3) at 2–5% concentration inhibits melanosome transfer from melanocytes to keratinocytes, reducing pigmentary dark circles over 8–12 weeks of consistent use. It also strengthens the skin barrier, reduces redness, and has a well-established safety profile in the eye area. DSM's Niacinamide is the reference supplier ingredient.

Caffeine at 1–2% concentration is the most clinically validated de-puffing and vascular brightening active for the eye area. Its mechanism involves vasoconstriction (reducing the appearance of visible blood vessels) and inhibition of phosphodiesterase (reducing fluid accumulation in periorbital tissue). BASF's Caffeine is the standard supplier ingredient. Clinical studies show visible reduction in puffiness within 15–30 minutes of application, making caffeine a key ingredient for "instant results" positioning.

Vitamin C derivatives — particularly Ascorbyl Glucoside (AA2G) and 3-O-Ethyl Ascorbic Acid (EAC) — provide antioxidant protection and melanin synthesis inhibition without the instability issues of L-ascorbic acid. At 2–3% concentration, they contribute to overall brightening and address oxidative stress-driven pigmentation.

Firming and Anti-Aging

Palmitoyl Tripeptide-5 is a signal peptide that stimulates TGF-β production, driving collagen synthesis in the dermis. At 0.1–0.3% concentration, it has demonstrated measurable improvements in skin firmness and reduction in fine line depth in clinical studies. Givaudan's Syn-Coll is the reference ingredient. Peptides are the most commercially resonant anti-aging actives for the eye area in 2026, combining genuine clinical efficacy with clean beauty compatibility.

Acetyl Hexapeptide-3 (Argireline) is a neurotransmitter-inhibiting peptide that reduces the depth of expression lines around the eyes by limiting acetylcholine release at the neuromuscular junction. At 5–10% concentration, it is one of the most commercially established actives for crow's feet reduction. Lipotec's Argireline Amplified is the premium supplier format.

Retinol (at low concentrations, 0.025–0.05%) can be incorporated into eye cream formulations for brands targeting the clinical anti-aging consumer, but requires careful formulation to manage the tolerability challenges that are amplified in the thin periorbital skin. Encapsulated retinol formats (such as DSM's Retinol HP-Cyclodextrin) provide a more tolerable delivery mechanism for the eye area.

De-Puffing and Lymphatic Drainage Support

Beyond caffeine, Centella Asiatica Extract (Cica) provides anti-inflammatory and wound-healing support that addresses puffiness driven by inflammation and compromised barrier function. Givaudan's Centella Asiatica Extract is the benchmark ingredient. Hesperidin Methyl Chalcone is a flavonoid that specifically targets vascular permeability in the periorbital area, reducing fluid accumulation and dark circles driven by vascular leakage.

Ingredient Interaction and Formulation Compatibility

Active Combination	Combined Benefit	Compatibility Notes
Multi-MW HA + Ceramide NP	Deep hydration + barrier repair	Fully compatible; ideal baseline
Niacinamide + Caffeine	Brightening + de-puffing	No compatibility issues; multi-benefit
Palmitoyl Tripeptide-5 + Argireline	Collagen + expression line reduction	Synergistic; avoid high-pH formulations
Caffeine + Hesperidin MC	Vascular brightening + de-puffing	Complementary mechanisms; excellent combination
Retinol + Ceramide NP	Anti-aging + barrier support	Ceramide mitigates retinol-induced barrier disruption
Squalane + Niacinamide	Emolliency + brightening	Lightweight luxury positioning

Texture Strategy: Matching Format to Consumer Segment

Eye cream texture is not merely a sensory preference — it is a positioning and efficacy decision. The six primary texture profiles for the eye area each serve a distinct consumer segment and formulation objective.

Rich Cream (high emollient content, 20–30% oil phase) targets the mature consumer seeking intensive overnight repair. It delivers maximum barrier support and emolliency but requires careful emulsifier selection to avoid milia risk. Best positioned as a night eye cream.

Gel-Cream (water-continuous emulsion with light oil phase, 5–10%) is the most versatile commercial format — suitable for morning and evening use, layers under makeup without pilling, and appeals to a broad age range. The dominant format in the mass-premium segment.

Lightweight Fluid (low-viscosity serum-cream hybrid) targets the younger consumer and the Asian beauty market, where lightweight textures are strongly preferred. High active ingredient loading is possible in fluid formats, supporting efficacy-led positioning.

Whipped Cream (aerated emulsion with mousse-like texture) is a premium sensory format that delivers a luxurious application experience. The aeration reduces the effective oil content while maintaining a rich feel, making it suitable for consumers who want luxury texture without heaviness.

Silky Serum (anhydrous or near-anhydrous oil-serum) appeals to the clean beauty and minimalist skincare consumer. High active concentration, fast absorption, and compatibility with the clean beauty aesthetic.

Yogurt Texture (high-water, low-oil emulsion with a distinctive thick-but-light consistency) is an emerging format with strong appeal in the K-beauty influenced segment. It delivers a cooling, soothing sensation on application that is particularly relevant for de-puffing positioning.

Clinical Efficacy Benchmarks: What to Expect from a Well-Formulated Eye Cream

Based on SEYE's reference formula clinical data (SGS/Intertek third-party testing), a well-formulated eye cream combining multi-molecular HA, ceramide NP, caffeine, niacinamide, and palmitoyl tripeptide-5 delivers the following measurable outcomes:

Timepoint	Hydration Improvement	Brightness Improvement	Smoothness Improvement	Puffiness Reduction
Week 4	+34% vs. baseline	+28% vs. baseline	+31% vs. baseline	−22% vs. baseline
Week 8	+52% vs. baseline	+41% vs. baseline	+46% vs. baseline	−35% vs. baseline
Week 12	+67% vs. baseline	+55% vs. baseline	+61% vs. baseline	−48% vs. baseline

These benchmarks provide the foundation for claim substantiation on finished products. For your specific formula, a consumer perception study (30–60 subjects, 4–8 weeks) conducted through a third-party CRO is required to substantiate claims on your packaging.

EU and US Compliance Considerations for Eye Cream OEM

Eye creams are regulated as cosmetics in both the EU (Regulation EC 1223/2009) and the US (FD&C Act, MoCRA). Key compliance considerations for OEM buyers include:

EU Regulation 1223/2009 requires a Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor before placing the product on the EU market. The CPSR must cover all ingredients at their use concentrations, with particular attention to preservative system compliance (Annex V), colorant compliance (Annex IV), and restricted substance compliance (Annex II/III). For eye area products, the preservative system requires additional scrutiny — phenoxyethanol is permitted at up to 1% in rinse-off and leave-on products, but some EU markets have additional guidance for eye area applications.

US MoCRA (Modernization of Cosmetics Regulation Act, 2023) introduced mandatory facility registration and product listing requirements for cosmetics sold in the US market. OEM buyers sourcing from China must ensure their manufacturing partner is MoCRA-registered and can provide the required documentation.

Ophthalmologist testing is not legally required but is strongly recommended for eye area products and is a meaningful marketing claim. Third-party ophthalmologist testing (conducted by a CRO with ophthalmology capabilities) provides the foundation for "ophthalmologist tested" on-pack claims and significantly reduces regulatory risk.

Building Your Private Label Eye Cream Range: A Strategic Framework

A commercially effective private label eye cream range typically comprises 2–3 SKUs targeting distinct consumer segments and price points:

The entry-level SKU (retail $25–45) uses a gel-cream texture with multi-molecular HA, caffeine, and niacinamide. It addresses the broadest consumer need (hydration + de-puffing + brightening) in a format that works for morning and evening use. This SKU drives trial and builds the brand's eye care credibility.

The hero SKU (retail $45–85) is the full-formula eye cream with the complete active stack — multi-molecular HA, ceramide NP, caffeine, niacinamide, palmitoyl tripeptide-5, and centella asiatica. It is positioned as the brand's clinical eye care solution and supports the strongest efficacy claims. This SKU drives revenue and brand authority.

The premium SKU (retail $85–150+) adds luxury actives — argireline, hesperidin methyl chalcone, encapsulated retinol, or a proprietary peptide complex — in a premium texture (whipped cream or silky serum) with luxury packaging. This SKU drives margin and brand prestige.

Why Eye Cream Belongs in Your OEM Portfolio in 2026

The global eye cream market was valued at approximately USD 3.2 billion in 2024 and is projected to grow at a CAGR of 5.8% through 2030, driven by aging demographics in North America and Europe, rising skincare sophistication in Southeast Asia and the Middle East, and the continued influence of K-beauty on global eye care routines. Eye cream is consistently among the highest-margin categories in skincare retail, with average selling prices significantly above comparable face cream formats.

For private label brands, eye cream offers a combination of high consumer demand, premium pricing, strong repeat purchase rates (driven by visible results and habitual use), and relatively low formulation complexity compared to active serums or SPF products. It is one of the most commercially reliable additions to any skincare portfolio.

Conclusion

Eye cream formulation is a discipline that rewards investment in ingredient science, texture engineering, and clinical validation. The brands that win in this category are those that understand the periorbital skin's unique requirements, select actives with genuine clinical support, and communicate their efficacy story with precision and credibility.

SEYE's luxury eye cream OEM program offers six customizable textures, a full active ingredient stack validated by third-party clinical testing, and complete compliance documentation for EU and US markets — with MOQ starting at 500 pcs and sample lead time of 7–14 days. Explore our Eye Cream OEM program or contact our R&D team to start your formulation brief today.